Teosyal RHA 4 Lidocaine (2x1.2ml)

Teosyal® RHA 4 Lidocaine (2x1.2ml) is a world-class professional aesthetic product expertly engineered to restore lost facial volume, correct deep age-related structural deficits, and perform advanced high-definition profile contouring. Utilizing TEOXANE’s patented Resilient Hyaluronic Acid (RHA®) technology to preserve the natural long-chain network of bio-fermented hyaluronic acid at a robust 23 mg/ml concentration, this premium 2x1.2ml treatment solution provides maximum vertical lifting capacity, dynamic tissue elasticity, and superior patient comfort via integrated lidocaine.

Product Overview

Teosyal® RHA 4 Lidocaine (2x1.2ml) provides aesthetic professionals with the heaviest, most resilient gel formulation in the premium Swiss RHA range, explicitly optimized for deep subcutaneous and supraperiosteal placement. Developed by the prestigious industry leader TEOXANE Laboratories (Geneva), this professional-use aesthetic product is powered by their innovative RHA® (Resilient Hyaluronic Acid) / Preserved Network Technology. Unlike traditional heavy volumizers that require dense chemical modifications which can result in rigid, immobile implants, TEOXANE’s proprietary processing method preserves the natural long-chain polymer matrix, utilizing an exceptionally low modification rate (~4.0%). This structures a highly cohesive, high-density gel that acts as a dynamic cushion. It stretches, flexes, and compresses in perfect synchronization with everyday human facial expressions while providing a powerful structural scaffold that effectively resists gravity and muscle compression.

What truly distinguishes this presentation within the global aesthetic market is its generous 2x1.2ml syringe configuration. Delivering a total of 2.4ml of high-performance structural gel per box, this upgraded layout gives cosmetic practitioners a significant volume advantage over standard 1ml alternatives. It offers ample material to thoroughly map and reconstruct broad facial sectors out of a single unit. Practitioners rely heavily on Teosyal RHA 4 to re-architect deflated contours and handle severe mid-face volume loss caused by age-related fat pad descent and bone remodeling. It performs flawlessly when augmenting the malar area (cheeks), defining the zygomatic arch, restructuring a weak chin profile, sharpening the jawline contour, and filling deep temporal hollows. Pre-mixed with 0.3% lidocaine hydrochloride to reduce localized tissue sensitivity, it lowers structural extrusion resistance to ensure a highly stable and relaxed clinical session.

Key Features

• Patented RHA® / Preserved Network Technology: Shields the long natural chains of high-molecular-weight HA, forming a highly flexible lattice with exceptional structural elasticity and volume support.
  
• Upgraded 1.2ml Syringe Format: Packaged as two single-use 1.2ml pre-filled syringes (2.4ml total volume), delivering 20% extra product per syringe to support large-scale multi-zone facial transformations.
  
• Maximum Elastic Modulus (): Engineered with high mechanical resistance to efficiently mimic native bone architecture and comfortably withstand heavy muscular pressure from the masseter and expressions.
  
• Low Modification Rate (~4.0%): Requires minimal chemical cross-linking agents (BDDE), resulting in an exceptionally pure, highly biocompatible matrix with a decreased risk of late-onset immunogenic reactions.
  
• Integrated Client Numbing: Infused with 3 mg/ml (0.3%) lidocaine hydrochloride to lower localized sensation during deep needle or cannula work.
  
• Advanced Migration Resistance: Extreme gel cohesion prevents the high-density material from shifting, spreading, or drifting away from the targeted deep plane.
  

Benefits for Professionals

• Crisp Structural Architecture: The exceptional structural integrity allows beauty clinics to achieve dramatic, crisp vertical lines on the cheeks, chin, and jawline, satisfying high client demands for contoured profiles.
  
• Exceptional Volume Efficiency: The generous 1.2ml syringe size enables medical spas to easily complete balanced, bilateral cheekbone augmentation or full-jawline mapping protocols without opening multiple boxes, optimizing product overhead.
  
• Eradicates the "Pillow Face" Look: Spreads uniformly within deep layers, filling structural hollows cleanly without creating artificial stiffness, unnatural contours, or water-logged pocket swelling in dynamic facial zones.
  
• Extended Volumetric Longevity: Thanks to the resilient polymer lattice that naturally bounces back from compression, results remain stable, full, and beautifully structured for 12 to 22 months.
  

Product Specifications

• Brand: Teosyal (TEOXANE)
  
• Product Line: Teosyal RHA® Series (Resilient Hyaluronic Acid)
  
• Volume: 2.4 ml total (2 x 1.2 ml pre-filled single-use syringes per box)
  
• Packaging: 2 pre-filled single-use syringes per box, sterilized and sealed, with four sterile single-use 27G 1/2" needles
  
• Active Ingredients: Resilient Hyaluronic Acid (23 mg/ml), Lidocaine Hydrochloride (3 mg/ml)
  
• Degree of Modification: ~4.0%
  
• Lifting Capacity: Maximum ( prime)
  
• Injection Depth: Deep dermis or subcutaneous tissue / supraperiosteal plane
  
• Duration: 12 to 22 months
  
• Manufacturer: TEOXANE Laboratories (Geneva, Switzerland)
  
• Storage Information: Store at room temperature between 2°C and 25°C (36°F to 77°F). Protect from direct sunlight and do not freeze.
  

Why Professionals Choose This Brand

The Teosyal RHA range by TEOXANE Laboratories enjoys unmatched world-class authority across the global aesthetic market, representing the absolute pinnacle of dynamic dermal filler science and Swiss precision engineering. Backed by rigorous international multi-center clinical trials, extensive safety registries, and widespread FDA approvals, its unique preservation paradigm sets a strict industry benchmark for purity. By protecting the integrity of the hyaluronic acid chains, TEOXANE provides clinics with an organic gel network that respects the dynamic, living nature of the human face.

Frequently Asked Questions (FAQ)

• What is Teosyal® RHA 4 Lidocaine (2x1.2ml) used for? It is a high-density, structural professional aesthetic product primarily utilized for deep tissue volume restoration, cheekbone augmentation, mid-face contouring, chin sculpting, jawline refinement, and filling deep subcutaneous tissue hollows.
  
• What makes the 2x1.2ml presentation a major clinical advantage? Standard dermal filler boxes typically contain 1.0ml syringes. TEOXANE’s upgraded RHA 4 packaging delivers 1.2ml per syringe (2.4ml total per box). This provides practitioners with 20% extra product per syringe, making it highly economical for executing large, deep bilateral cheek restorations or multi-zone profile sculpting without needing to open additional boxes.
  
• How does Teosyal RHA 4 differ from Teosyal RHA 3? While both variants share a 23 mg/ml concentration and utilize premium RHA technology, they are calibrated for completely different tissue depths and mechanical tasks. Teosyal RHA 3 is designed with intermediate density for treating deep wrinkles and lines (like nasolabial folds) or structural lip shaping. Teosyal RHA 4 is engineered with the highest level of cross-linking node density, viscosity, and lifting cohesion in the series, making it substantially firmer and strictly tailored for deep subcutaneous volume replacement and bone-mimicking projection.
  
• How long do the structural volumizing results typically last? Thanks to its highly structured, resilient polymer lattice that naturally bounces back from repeated muscle compression and resists enzymatic degradation, the lifting and contouring effects of Teosyal RHA 4 remain stable, chiseled, and highly visible for 12 to 22 months.